BONEX Bonesupport Holding AB (publ)

31.87USD323.80 SEK · STO+1.63%Mkt Cap: 2.07B USDP/E: 79.36

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.07B USD
Enterprise Value2.03B USD
Revenue (TTM)137.91M USD
Gross Profit107.03M USD
Net Income (TTM)13.99M USD
Revenue/Share2.10 USD
Last Price31.87 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees174
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0009858152
Valuation
P/E (Trailing)79.36
P/E (Forward)74.10
PEG—
EV/EBITDA57.40
EV/Revenue14.72
P/S15.03
P/B21.28
EPS (TTM)0.40 USD
EPS (Forward)0.43 USD
52W Range
16.2491% of range33.49
52W High33.49 USD
52W Low16.24 USD
Profitability
Gross Margin92.57%
Oper. Margin25.49%
EBITDA Margin25.64%
Profit Margin12.10%
ROE16.39%
ROA13.72%
ROIC39.48%
ROCE31.84%
Growth
Revenue Growth39.00%
Earnings Growth167.30%
Cash Flow & Leverage
Operating CF21.78M USD
CapEx (TTM)511.34K USD
FCF Margin12.95%
FCF Yield0.86%
Net Debt-49.20M USD
Net Debt/EBITDA-1.39
Net Debt/FCF-2.76
Balance Sheet
Debt/Equity0.01
Current Ratio5.73
Quick Ratio4.28
Book Value/Sh1.50 USD
Cash/Share0.77 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)36.88 USD
Upside (mean)+15.7%
Target Range27.56 USD – 40.85 USD
27.56+15.7% to mean40.85
# Analysts6
Ownership
Shares Out.65.03M
Float58.25M
Insiders8.93%
Institutions58.14%
Technical
SMA 5026.22 (+21.6%)
SMA 20022.59 (+41.1%)
Beta0.27
S&P 52W Chg12.00%
Avg Vol (30d)380.78K
Avg Vol (10d)255.53K
Technical Indicators
RSI (14)62.4
MACD13.9180
MACD Signal17.0765
MACD Hist.-3.1585
BB Upper32.94 USD
BB Middle31.59 USD
BB Lower30.25 USD
BB Width8.54%
ATR (14)1.111 USD
Vol Ratio (20d)0.43x

About Bonesupport Holding (STO: BONEX)

›

Bonesupport Holding (STO: BONEX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 174 employees.

The shares were at 323.80 SEK on 19 November 2026, up 56.0% over 52 weeks. Its 52-week range is 165.00 SEK to 340.20 SEK: the price is 4.8% below the high and 96.2% above the low.

At a market capitalisation of 21.06B SEK, it trades at 79.4 times trailing earnings and 74.1 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a premium of 61% for BONEX.

Bonesupport Holding reports return on equity of 16.4%, an operating margin of 25.5% and revenue up 39.0% year over year.

It holds more cash than debt, a net cash position of 499.89M SEK. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 6 analysts cover the stock; their mean price target of 374.67 SEK is 15.7% above the current price. The next earnings report is expected on 15 February 2027.